Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
COMBINATORX Add to My Watchlist (NSDQ: CRXX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     CombinatoRx 1.17 -0.01 (-0.85%) 228,171
245 First Street
Sixteenth Floor
Cambridge, MA 02142 US
(617) 301-7000
(617) 301-7010 fax
www.combinatorx.com
CEO Mark H.N. Corrigan
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US20010A1034
CIK Number 1135906
NAICS Code 325412
Business Summary
A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals and has a product portfolio in Phase 2 clinical development.
Number of Employees 73
Share Fundamentals
Market Cap 41.02M
Shares Outstanding 35.06M
Float 34.69M
Short Interest 105.20K
Financial Strength
Revenue (TTM) $13,001,000
Earnings (TTM) -$25,017,000
Quick Ratio 1.4:1
Current Ratio 1.6:1
Total Debt/Equity 0.19:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs